Rheumatoid Arthritis Burden in Middle-Aged Adults (40–59 Years): Evidence from the Global Burden of Disease 2021

Key Points

• To assess the burden of rheumatoid arthritis in middle-aged adults using global disease data from 1990 to 2021.
• Analysis of global burden of disease data
• Evaluation of age-standardized incidence rates (ASIR)
• Assessment of age-standardized prevalence rates (ASPR)
• Examination of age-standardized mortality rates (ASMR)
• Study of age-standardized disability rates (ASDR)
• Increasing age-standardized incidence rate (ASIR) noted from 1990 to 2021
• Rising age-standardized prevalence rate (ASPR) among the same demographic
• Decline in age-standardized mortality rate (ASMR) observed during the period
• Age-standardized disability rate (ASDR) remained relatively stable
• Projections indicate that ASIR and ASPR will remain steady while ASMR and ASDR will decrease.

Abstract